Bio-Techne: Kim Kelderman, Chuck Kummeth
Bio-Techne's board has appointed Kim Kelderman as president and CEO, effective Feb. 1, 2024. He will replace Chuck Kummeth who is retiring after a decade as president, CEO, and board director. Kummeth will be a senior advisor to Kelderman from Feb. 1, 2024 until July 1, 2024 when he will retire.
Before becoming CEO, Kelderman will become Bio-Techne's COO, effective Nov. 1. He will join the firm's board upon assuming the CEO position. Kelderman has been president of Bio-Techne's Diagnostics and Genomics segment since joining the firm in 2018. Before that, he was at Thermo Fisher Scientific where he led its Genetic Sciences division. He also was senior segment leader at Becton Dickinson. Kelderman currently is on the board of StatLab Medical Products, a developer and manufacturer of diagnostic supplies and equipment for the anatomic pathology market.